The pandemic of coronavirus disease 2019 has inflicted millions of people in the world and caused severe complications in immunocompromised individuals. Some evidences suggest that severe COVID-19 complications are associated with the cytokine storm syndrome, contributing to the high mortality rate of the disease. Asthma is a complicated disease of the respiratory system. COVID-19 symptoms can be worse in asthmatic patients than others. Corticosteroids with anti-inflammatory functions which are used in asthmatic patients may have adverse outcomes in coronavirus infection and are not recommended for the treatment of COVID-19. Furthermore, asthmatic patients (using inhalation corticosteroids) have a suppressed immune system in the lung, which increases their susceptibility to COVID-19 infection.
Dr. Athari is an Assistant Professor of immunology at the Department of Immunology, School of Medicine, Zanjan University of Medical Sciences. He has an allergy and asthma toxicology post-doctorate degree, asthma management and controlling network fellowship and MPH in health policy of asthma. He has published more than 100 manuscripts in international journals on immunology, allergy and asthma and more than 30 books. He is also on the editorial board of more than 75 international journals in medical sciences and has more than 12 inventions in medical sciences and has recorded 12 gene sequences in the gene bank. Dr. Athari has been invited as top speaker for more than 45 international congresses and symposiums and has received several scientific awards from different scientific societies as a young top researcher and young scientist.